Estudo randomizado | Em pacientes com doenças inflamatórias imunomediadas (artrite reumatoide, espondiloartrite, artrite psoriática, colite ulcerativa, doença de Crohn ou psoríase) tratadas com infliximabe, um protocolo de monitoramento proativo dos níveis da medicação teve maior chance de levar a um controle sustentado da doença.
17 Jan, 2022 | 12:44hEffect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial – JAMA (link para o resumo – $ para o texto completo)
Comentário no Twitter
Study found proactive therapeutic drug monitoring (TDM) compared with treatment without TDM during maintenance infliximab therapy was more likely to lead to sustained disease control over 52 weeks for patients with immune-mediated inflammatory diseases https://t.co/yfJjyADaOT pic.twitter.com/JtOfQxFFDS
— JAMA (@JAMA_current) December 21, 2021